Avanos Medical Inc (AVNS)

Financial leverage ratio

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Total assets	US$ in thousands	1,154,200	1,656,200	1,657,800	1,661,300	1,692,400	1,724,900	1,666,700	1,734,900	1,786,900	1,775,200	1,752,800	1,766,500	1,594,600	1,597,900	1,683,300	1,648,800	1,672,800	1,799,100	1,755,900	1,763,700
Total stockholders’ equity	US$ in thousands	828,500	1,229,700	1,222,000	1,227,900	1,236,300	1,222,100	1,234,800	1,298,700	1,291,200	1,263,500	1,251,600	1,256,500	1,263,900	1,261,900	1,296,300	1,252,600	1,256,500	1,289,900	1,261,600	1,256,500
Financial leverage ratio		1.39	1.35	1.36	1.35	1.37	1.41	1.35	1.34	1.38	1.40	1.40	1.41	1.26	1.27	1.30	1.32	1.33	1.39	1.39	1.40

December 31, 2024 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $1,154,200K ÷ $828,500K
= 1.39

The financial leverage ratio of Avanos Medical Inc has shown a fluctuating trend over the period from March 31, 2020, to December 31, 2024. The ratio started at 1.40 in March 2020 and reached its peak of 1.41 in March 2022. The ratio then gradually declined to 1.35 by June 30, 2024, before slightly increasing to 1.39 by December 31, 2024.

Overall, the financial leverage ratio of Avanos Medical Inc indicates the company's reliance on debt financing relative to its equity. The fluctuations in the ratio suggest changes in the company's capital structure and financial risk levels over the analyzed period. It is important for stakeholders to closely monitor the financial leverage ratio to assess the company's ability to meet its debt obligations and sustain its operations effectively.